Adverse event reporting during clinical trials is a critical component in the drug approval process, ensuring patient safety and regulatory integrity. Accurate and timely documentation of adverse events facilitates informed decision-making by authorities and researchers alike. Understanding the regulatory framework governing these reports—spanning international guidelines and national regulations—is essential for compliance and safeguarding public health….